Charles River Laboratories | CRL - Ordinary Share Capital

Stock Price
201.41
Daily Change
-11.81 -5.54%
Monthly
-3.32%
Yearly
23.47%
Q1 Forecast
204.00

Charles River Laboratories reported $49.22M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Agilent USD 283.05M 540K Sep/2025
Align Technology USD 72.49M 0 Sep/2025
Bio-Rad Laboratories USD 27.06M 571K Jun/2025
Bruker USD 151.72M 149.92M Sep/2025
Cardinal Health USD 238M 1000K Sep/2025
Charles River Laboratories USD 49.22M 6K Sep/2025
Cigna USD 266.6M 262.6M Jun/2025
CVS Health USD 1.27B 3M Sep/2025
Danaher USD 706.9M 600K Dec/2025
Dentsply International USD 199.5M 196.5M Sep/2025
Elevance Health USD 222.24M 2.94M Dec/2025
Galapagos EUR 65.9M 0 Sep/2025
Hologic USD 222.57M 350K Sep/2025
Humana USD 120.27M 87.27M Sep/2025
Illumina USD 153.7M 300K Sep/2025
Incyte USD 196.13M 2.01M Sep/2025
IQVIA Holdings USD 170.3M 300K Sep/2025
Laboratory Of America USD 82.9M 75.3M Jun/2025
Lonza CHF 72M 0 Dec/2024
McKesson USD 124M 1000K Sep/2025
Merck EUR 434.78M 130.22M Jun/2025
Mettler Toledo International USD 20.6M 0 Sep/2025
Novartis USD 1.94B 23.4M Jun/2025
Pfizer USD 5.69B 1000K Sep/2025
Quest Diagnostics USD 111M 1000K Sep/2025
Revvity USD 116.07M 258K Sep/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
United Therapeutics USD 42.9M 42.1M Sep/2025
UnitedHealth USD 905.84M 161K Dec/2025
Waters USD 59.52M 11K Sep/2025
West Pharmaceutical Services USD 71.9M 0 Sep/2025